Delivery Order SPE2DB20D3103-SPE2DB25FP7J1
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a contract ceiling value of $1,310.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities, with a ceiling value of $6,776.02 and an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This contract, valued at $23,775.26, represents a firm fixed price delivery order with a completion date of June 2, 2025. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical procurement standards through open competition. The...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 8, 2024, for the supply of Opzelura 1.5% cream in 60-gram units, valued at $22,363.62. This firm fixed price delivery order, with an ultimate completion date of November 12, 2024, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $26,873.19 delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 16, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $7,523.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This non-set-aside contract, which must be completed by September 5, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be performed and delivered from the contractor's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a $7,140.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream on April 21, 2025, with completion expected by April 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for OPZELURA 1.5% Cream (60 grams) valued at $5,888.90 with a firm fixed price structure. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,799.47 on June 27, 2025, for the supply of Opzelura 1.5% Cream (60gm), a pharmaceutical product with a completion date of June 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $8,510.74 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award issued on August 11, 2025. The award will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...